Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | +65.40% | −6.42% | −5.13% | −7.66% | +41.51% | +82.81% | +90.48% | +834.45% | +232.07% | +263.26% |
| ES-GENOME | +62.79% | +0.74% | +3.41% | −8.31% | +27.43% | +59.28% | +52.50% | +72.28% | −45.83% | −53.44% |
| BCARE | +14.91% | +1.99% | +5.09% | +8.23% | +8.14% | +17.30% | +23.16% | +33.14% | +7.17% | +16.51% |
| TGENOME | +55.52% | −0.24% | +2.14% | −7.49% | +24.01% | +51.64% | +48.81% | +74.34% | −46.57% | −56.04% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes NTRA: money market or bond funds, or no holdings data yet
| ES-GENOME | TGENOME | |
|---|---|---|
| Held by both | ||
 Twist Bioscience | 10.83% | 8.90% |
 10x Genomics | 10.50% | 7.84% |
 Tempus AI Inc Class A common… | 9.36% | 6.99% |
 CRISPR Therapeutics | 5.49% | 4.10% |
 Absci | 5.30% | 3.96% |
 Natera | 4.75% | 3.92% |
| Personalis | 5.12% | 3.82% |
 Illumina | 4.71% | 3.80% |
 Guardant Health | 4.83% | 3.61% |
 CareDx | 4.55% | 3.40% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| ES-GENOME | +62.79% | 42.39% | 1.48 |
| TGENOME | +55.52% | 40.24% | 1.38 |
| NTRA | +65.40% | 52.61% | 1.24 |
| BCARE | +14.91% | 15.93% | 0.94 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | NTRA | ES-GENOME | BCARE | TGENOME |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 225 million | 4,712 million | 1,372 million |
| Inception date | N/A | 23 Mar 2021 | 29 Aug 2007 | 13 Jan 2021 |
| Master fund | N/A | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution UCITS, ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | Wellington Global Health Care Equity Fund | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare, ISHARES BIOTECHNOLOGY) |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 79.06% | 47.41% | 84.93% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 1 THB | 500 THB | 1,000 THB |
| Subsequent purchase | N/A | 1 THB | 500 THB | 1,000 THB |
| Redemption (amount) | N/A | 1 THB | No minimum | No minimum |
| Redemption (units) | N/A | 1 units | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | No minimum | No minimum |
| Balance (units) | N/A | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+4 | T+3 |
